Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

ClinicalTrials.gov ID: NCT01109004

Public ClinicalTrials.gov record NCT01109004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN 0702)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed as a Phase III, multicenter trial of tandem autologous transplants plus maintenance therapy versus the strategy of single autologous transplant plus consolidation therapy with lenalidomide, bortezomib and dexamethasone (RVD) followed by maintenance therapy or single autologous transplant plus maintenance therapy as part of upfront treatment of multiple myeloma (MM). Lenalidomide will be used as maintenance therapy for three years in all arms.

Study identification

NCT ID
NCT01109004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
758 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2010 (Actual)
Primary completion
Jan 15, 2017 (Actual)
Completion
Mar 3, 2018 (Actual)
Last update posted
Dec 9, 2021

2010 – 2018

United States locations

U.S. sites
54
U.S. states
28
U.S. cities
49
Facility City State ZIP Site status
Arizona Cancer Center Tucson Arizona 85724 —
City of Hope National Medical Center Duarte California 91010-3000 —
UCSD Medical Center La Jolla California 92093 —
University of California, San Francisco San Francisco California 94143-0324 —
Stanford Hospital and Clinics Stanford California 94305 —
Colorado Blood Cancer Institute Denver Colorado 80218 —
Christiana Care Health System Newark Delaware 19718 —
University of Florida College of Medicine Gainesville Florida 32610 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
H. Lee Moffitt Cancer Center Tampa Florida 33624 —
Blood and Marrow Transplant Program at Northside Hospital Atlanta Georgia 30342 —
Georgia Health Sciences University Augusta Georgia 30912 —
St. Lukes Mountain States Tumor Institute Boise Idaho 83712 —
Rush University Medical Center Chicago Illinois 60612 —
University of Illinois Chicago Illinois 60612 —
Advocate Lutheran General Hospital Park Ridge Illinois 60068 —
University of Kansas Hospital Kansas City Kansas 66160 —
Wichita CCOP Wichita Kansas 67214 —
University of Kentucky Lexington Kentucky 40536 —
Louisiana State University Health Sciences Center Shreveport Louisiana 71130 —
DFCI, Brigham and Womens Hospital Boston Massachusetts 02114 —
DFCI, Massachusetts General Hospital Boston Massachusetts 02114 —
University of Michigan Medical Center Ann Arbor Michigan 48105-2967 —
Karmanos Cancer Institute/BMT Detroit Michigan 48201 —
University of Minnesota Minneapolis Minnesota 55455 —
Washington University, Barnes Jewish Hospital St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198-7680 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Cancer Center Buffalo New York 14263 —
North Shore University Hospital Lake Success New York 11042 —
Mount Sinai Medical Center New York New York 10029 —
Memorial Sloan-Kettering Cancer Center New York New York 10174 —
University of Rochester Medical Center Rochester New York 14642 —
University of North Carolina Hospital at Chapel Hill Chapel Hill North Carolina 27599-7305 —
Duke University Medical Center Durham North Carolina 27705 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Jewish Hospital BMT Program Cincinnati Ohio 45236 —
University Hospitals of Cleveland Cleveland Ohio 44106-5061 —
Ohio State/Arthur G. James Cancer Hospital Columbus Ohio 43210 —
University of Oklahoma Medical Center Oklahoma City Oklahoma 73104 —
Oregon Health & Science University Portland Oregon 97239-3098 —
Penn State College of Medicine, The Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104 —
Thompson Cancer Survival Center Knoxville Tennessee 37916 —
Sarah Cannon Blood & Marrow Transplant Program Nashville Tennessee 37203 —
Vanderbilt University Medical Center Nashville Tennessee 37232-8210 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine/The Methodist Hospital Houston Texas 77030 —
University of Texas, MD Anderson CRC Houston Texas 77030 —
Texas Transplant Institute San Antonio Texas 78229 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024 —
West Virginia University Hospital Morgantown West Virginia 26506 —
University of Wisconsin Hospital & Clinics Madison Wisconsin 53792-5156 —
Medical College of Wisconsin Milwaukee Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01109004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01109004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →